Linnea

Linnea®
Vincamine

PLANT

Voacanga africana

PART OF THE PLANT USED

Seeds

APPEARANCE

White crystalline microcrystalline powder

CAS NUMBER

1617-90-9

Linnea® Vincamine

Linnea’s Vinpocetine and Vincamine are extracted from Voacanga Africana seeds directly at our Swiss manufacturing site.

Uses

Pharmaceutical

• Cerebral circulation modulation
• Dizziness, vertigo (Ménière’s disease)

Dietary ingredients

• Brain performance (anti-hypoxic activity)
• Neuroprotective effect
• Concentration and memory
• Body performance

Products

Pharmaceutical

VINCAMINE
Semi-synthetic derivative

Dietary Ingredients

VINCAMINE
Semi-synthetic derivative

Features

Sustainable, no risk of deforestation

Complies with Ph. Eur. “Vincamine” monograph, current edition

get in touch with us

The logo indicates that Linnea is compliant with the European Pharmacopoeia standards for producing Vincamine.

Ph. Eur.

The logo indicates that Linnea is CEP certified for producing Vincamine. CEP stands for Certificate of Suitability to the monographs of the European Pharmacopoeia.

CEP

(in process)

The logo indicates that Linnea Natural Pharma Solutions has created a DMF for producing Vincamine. DMF stands for Drug Master Files which details information about the manufacturing processes of Linnea.

DMF

The logo indicates that, while producing Vincamine, Linnea’s facility remains GMP certified. GMP stands for Good Manufacturing Practices.

GMP compliant by Swissmedic

READ LINNEA’S MEDIA ARCHIVE

Education, Community and Thought Leadership

Linnea goes beyond manufacturing to support our customers, connect with the community, and educate worldwide about the potential therapeutic benefits of our ingredients

follow LINNEA on linkedin

Get the latest
Linnea® news